Modulating neurotoxicity through CX3CL1/CX3CR1 signaling

Cristina Limatola1, Richard M Ransohoff2

  • 1Department of Physiology and Pharmacology, Istituto Pasteur Fondazione Cenci Bolognetti, Sapienza University of Rome Rome, Italy ; Istituto di Ricovero e Cura a Carattere Scientifico Neuromed, Istituto Neurologico Mediterraneo Pozzilli, Italy.

Summary

Fractalkine (CX3CL1) and its receptor (CX3CR1) mediate crucial microglia-neuron interactions. This signaling pathway influences brain development, function, and neuroprotection across various neurological diseases.